Target Name: C9orf78
NCBI ID: G51759
Review Report on C9orf78 Target / Biomarker Content of Review Report on C9orf78 Target / Biomarker
C9orf78
Other Name(s): bA409K20.3 | HCA59 | Hepatocellular carcinoma-associated antigen 59 | CSU2 | Chromosome 9 open reading frame 78 | TLS1 | TLS1_HUMAN | hepatocellular carcinoma-associated antigen 59 | HSPC220 | Telomere length and silencing protein 1 homolog | uncharacterized protein C9orf78 | chromosome 9 open reading frame 78 | BA409K20.3

Unraveling the Potential Applications of C9orf78 (bA409K20.3) as a Drug Target and Biomarker

Introduction

C9orf78 (bA409K20.3), also known as centroglobulin, is a large protein with a molecular weight of 409 kDa. It plays a variety of biological functions in organisms, such as cell signaling, cell adhesion, cell migration and cell proliferation. At the same time, it also has potential application value in certain diseases, such as cancer, neurodegenerative diseases, and autoimmune diseases. Therefore, studying C9orf78 as a drug target and biomarker has important clinical significance.

drug target

As a protein, C9orf78 can be used as a drug target to interfere with intracellular biochemical processes. The mechanism of action of many drugs is to interfere with its biological function by specifically binding to C9orf78. At present, C9orf78 has become an important target in many drug research, including anti-tumor drugs, antidepressants, antipsychotics and immunomodulators.

1. Anti-tumor drugs

Research on anti-tumor drugs mainly focuses on C9orf78 regulating the growth, proliferation and apoptosis of tumor cells. C9orf78 can affect the biological behavior of tumor cells in a variety of ways, such as inhibiting the proliferation of tumor cells by inhibiting the phosphorylation of C9orf78, affecting the adhesion and migration of tumor cells by regulating the interaction between C9orf78 and cell adhesion proteins, and regulating Modification of C9orf78 affects tumor cell apoptosis.

2. Antidepressants

Research on antidepressant drugs mainly focuses on C9orf78 regulating the biological behavior of nerve cells, such as nerve cell proliferation, neuronal connections, and neurotransmitter release. C9orf78 can affect the biological behavior of nerve cells in a variety of ways, such as by regulating the interaction between C9orf78 and receptors in nerve cells to affect neuronal excitability and neurotransmitter release, and by regulating the phosphorylation of C9orf78. Neuronal proliferation and apoptosis.

3. Antipsychotics

Research on antipsychotic drugs mainly focuses on C9orf78 regulating the biological behavior of nerve cells, such as nerve cell proliferation, neuronal connections, and neurotransmitter release. C9orf78 can affect the biological behavior of nerve cells in a variety of ways, such as by regulating the interaction between C9orf78 and receptors in nerve cells to affect neuronal excitability and neurotransmitter release, and by regulating the phosphorylation of C9orf78. Neuronal proliferation and apoptosis.

4. Immunomodulators

Research on immunomodulators mainly focuses on the biological functions of C9orf78 in immune cells, such as activation of T cells, activation of B cells and proliferation of immune cells. C9orf78 can affect the biological behavior of immune cells in a variety of ways, such as affecting the activation and proliferation of immune cells by regulating the interaction between C9orf78 and receptors in immune cells, and affecting the apoptosis of immune cells by regulating the phosphorylation of C9orf78..

Biomarkers

C9orf78 also has potential as a biomarker in certain diseases. For example, in cancer, C9orf78 can be used as a marker of tumor tissue to evaluate the malignancy of tumor tissue and monitor tumor progression by detecting the expression level of C9orf78. In neurodegenerative diseases, C9orf78 can be used as a marker of neural tissue to assess the health of neural tissue and monitor disease progression by detecting the expression level of C9orf78.

Conclusion

As a protein, C9orf78 plays a variety of biological functions in organisms and can also be used as a drug target or biomarker. With the deepening of research, C9orf78 has broad application prospects in drug research and biomedical research. Future research can further reveal the mechanism of action of C9orf78 in vivo and provide a theoretical basis for the development of new drugs and biomedical products.

Protein Name: Chromosome 9 Open Reading Frame 78

Functions: Plays a role in pre-mRNA splicing by promoting usage of the upstream 3'-splice site at alternative NAGNAG splice sites; these are sites featuring alternative acceptor motifs separated by only a few nucleotides (PubMed:35241646). May also modulate exon inclusion events (PubMed:35241646). Plays a role in spliceosomal remodeling by displacing WBP4 from SNRNP200 and may act to inhibit SNRNP200 helicase activity (PubMed:35241646). Binds U5 snRNA (PubMed:35241646). Required for proper chromosome segregation (PubMed:35167828). Not required for splicing of shelterin components (PubMed:35167828)

The "C9orf78 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C9orf78 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

C9orf78P2 | C9orf85 | CA1 | CA10 | CA11 | CA12 | CA13 | CA14 | CA15P1 | CA2 | CA3 | CA3-AS1 | CA4 | CA5A | CA5B | CA5BP1 | CA6 | CA7 | CA8 | CA9 | CAAP1 | CAB39 | CAB39L | CABCOCO1 | CABIN1 | CABLES1 | CABLES2 | CABP1 | CABP2 | CABP4 | CABP5 | CABP7 | CABS1 | CABYR | CACFD1 | CACHD1 | CACNA1A | CACNA1B | CACNA1C | CACNA1C-AS4 | CACNA1C-IT2 | CACNA1C-IT3 | CACNA1D | CACNA1E | CACNA1F | CACNA1G | CACNA1G-AS1 | CACNA1H | CACNA1I | CACNA1S | CACNA2D1 | CACNA2D1-AS1 | CACNA2D2 | CACNA2D3 | CACNA2D4 | CACNB1 | CACNB2 | CACNB3 | CACNB4 | CACNG1 | CACNG2 | CACNG2-DT | CACNG3 | CACNG4 | CACNG5 | CACNG6 | CACNG7 | CACNG8 | CACTIN | CACTIN-AS1 | CACUL1 | CACYBP | CAD | CADM1 | CADM2 | CADM3 | CADM3-AS1 | CADM4 | CADPS | CADPS2 | CAGE1 | CAHM | CALB1 | CALB2 | CALCA | CALCB | Calcium channel | Calcium release-activated channel (CRAC) | Calcium-activated chloride channel regulators | Calcium-Activated K(Ca) Potassium Channel | CALCOCO1 | CALCOCO2 | CALCR | CALCRL | CALCRL-AS1 | CALD1 | CALHM1 | CALHM2 | CALHM3 | CALHM4